Decreased expression of GGA3 protein in Alzheimer's disease frontal cortex and increased co-distribution of BACE with the amyloid precursor protein - PubMed (original) (raw)
Comparative Study
doi: 10.1016/j.nbd.2011.03.009. Epub 2011 Apr 3.
Affiliations
- PMID: 21440067
- DOI: 10.1016/j.nbd.2011.03.009
Comparative Study
Decreased expression of GGA3 protein in Alzheimer's disease frontal cortex and increased co-distribution of BACE with the amyloid precursor protein
Claudia Santosa et al. Neurobiol Dis. 2011 Jul.
Abstract
BACE initiates the amyloidogenic processing of the amyloid precursor protein (APP) that results in the production of Aβ peptides associated with Alzheimer's disease (AD). Previous studies have indicated that BACE is elevated in the frontal cortex of AD patients. Golgi-localized γ-ear containing ADP ribosylation factor-binding proteins (GGA) control the cellular trafficking of BACE and may alter its levels. To investigate a link between BACE and GGA expression in AD, frontal cortex samples from AD (N = 20) and healthy, age-matched controls (HC, N =17) were analyzed by immunoblotting. After normalization to the neuronal marker β-tubulin III, the data indicate an average two-fold increase of BACE protein (p = 0.01) and a 64% decrease of GGA3 in the AD group compared to the HC (p = 0.006). GGA1 levels were also decreased in AD, but a statistical significance was not achieved. qRT-PCR analysis of GGA3 mRNA showed no difference between AD and HC. There was a strong correlation between GGA1 and GGA3 in both AD and HC, but no correlation between BACE and GGA levels. Subcellular fractionation of AD cortex with low levels of GGA proteins showed an alteration of BACE distribution and extensive co-localization with APP. These data suggest that altered compartmentalization of BACE in AD promotes the amyloidogenic processing of APP.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
- Caspase-3 cleavage of GGA3 stabilizes BACE: implications for Alzheimer's disease.
Vassar R. Vassar R. Neuron. 2007 Jun 7;54(5):671-3. doi: 10.1016/j.neuron.2007.05.018. Neuron. 2007. PMID: 17553417 Review. - Elucidation of the BACE1 regulating factor GGA3 in Alzheimer's disease.
Natunen T, Parrado AR, Helisalmi S, Pursiheimo JP, Sarajärvi T, Mäkinen P, Kurkinen KM, Mullin K, Alafuzoff I, Haapasalo A, Bertram L, Soininen H, Tanzi RE, Hiltunen M. Natunen T, et al. J Alzheimers Dis. 2013;37(1):217-32. doi: 10.3233/JAD-130104. J Alzheimers Dis. 2013. PMID: 23970038 - Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients.
Li R, Lindholm K, Yang LB, Yue X, Citron M, Yan R, Beach T, Sue L, Sabbagh M, Cai H, Wong P, Price D, Shen Y. Li R, et al. Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3632-7. doi: 10.1073/pnas.0205689101. Epub 2004 Feb 20. Proc Natl Acad Sci U S A. 2004. PMID: 14978286 Free PMC article. - Β-site APP-cleaving enzyme 1 trafficking and Alzheimer's disease pathogenesis.
Tan J, Evin G. Tan J, et al. J Neurochem. 2012 Mar;120(6):869-80. doi: 10.1111/j.1471-4159.2011.07623.x. Epub 2012 Jan 23. J Neurochem. 2012. PMID: 22171895 Review. - Retromers in Alzheimer's disease.
Siegenthaler BM, Rajendran L. Siegenthaler BM, et al. Neurodegener Dis. 2012;10(1-4):116-21. doi: 10.1159/000335910. Epub 2012 Mar 3. Neurodegener Dis. 2012. PMID: 22398391 Review.
Cited by
- BACE1 elevation engendered by GGA3 deletion increases β-amyloid pathology in association with APP elevation and decreased CHL1 processing in 5XFAD mice.
Kim W, Ma L, Lomoio S, Willen R, Lombardo S, Dong J, Haydon PG, Tesco G. Kim W, et al. Mol Neurodegener. 2018 Feb 2;13(1):6. doi: 10.1186/s13024-018-0239-7. Mol Neurodegener. 2018. PMID: 29391027 Free PMC article. - Mechanisms underlying insulin deficiency-induced acceleration of β-amyloidosis in a mouse model of Alzheimer's disease.
Devi L, Alldred MJ, Ginsberg SD, Ohno M. Devi L, et al. PLoS One. 2012;7(3):e32792. doi: 10.1371/journal.pone.0032792. Epub 2012 Mar 5. PLoS One. 2012. PMID: 22403710 Free PMC article. - Critical analysis of the use of β-site amyloid precursor protein-cleaving enzyme 1 inhibitors in the treatment of Alzheimer's disease.
Evin G, Barakat A. Evin G, et al. Degener Neurol Neuromuscul Dis. 2014 Jan 22;4:1-19. doi: 10.2147/DNND.S41056. eCollection 2014. Degener Neurol Neuromuscul Dis. 2014. PMID: 32669897 Free PMC article. Review. - Dysregulation of protein trafficking in neurodegeneration.
Wang X, Huang T, Bu G, Xu H. Wang X, et al. Mol Neurodegener. 2014 Aug 25;9:31. doi: 10.1186/1750-1326-9-31. Mol Neurodegener. 2014. PMID: 25152012 Free PMC article. Review. - Sorting Out Sorting Nexins Functions in the Nervous System in Health and Disease.
Vieira N, Rito T, Correia-Neves M, Sousa N. Vieira N, et al. Mol Neurobiol. 2021 Aug;58(8):4070-4106. doi: 10.1007/s12035-021-02388-9. Epub 2021 May 1. Mol Neurobiol. 2021. PMID: 33931804 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical